Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Drug Action II > Block 1: GERD and PUD Pharm > Flashcards

Block 1: GERD and PUD Pharm Flashcards

1
Q

What is the cause of GERD?

A

Retrograde reflux of gastric content (acid-pepsin) coupled with imcompetent esophagi-gastric junction → esophageal mucosa erosion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the mechanisms of esophago-gastric junction incompetence?

A
  1. Abnormal lower esophageal sphincter (LES) relaxations caused by gastric distention
  2. LES hypotension
  3. Anatomic distortion of the esophagi-gastric junction → hiatus hernia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are exacerbating factors for reflux?

A
  1. Abdominal obesity
  2. Pregnancy
  3. Defective clearance of reflux from the esophagus
  4. Impaired esophageal mucosal defense
  5. Disruption of esophageal peristalsis
  6. Delayed gastric emptying
  7. Gastric hypersecretory states
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What mechansims do we target to treat GERD?

A
  1. Neutralizing and suppressing gastric acid to treat GERD
  2. Enhancing esophago-gastric peristalsis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why do we neutralize and suppress gastric acid to treat GERD?

A

Most sx stem from injury to esophageal epithelium with acid-pepsin content, however, gastric acid is not the only cause.

Pepsin, bile, and pancreatic enzymes can also cause damage

Harmful properties are more prominent in an acidic environment and require acid for activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do we neutralize acid for GERD?

A

Acid reducing agents: Antacids, H2-blockers, PPIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why do we enhance esophago-gastric peristalsis to treat GERD?

A

Increasing LES tone improves reflux clearance and gastric emptying

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do enhance esophago-gastric peristalsis?

A

Prokinetic drugs/motility enhancers: Bethanechol (Cholinomimetic), Metoclopramide (D2 + 5-HT3 receptors antagonist)]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is PUD?

A

Chronic and recurrence disease that compases GU and DU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What protects the stomach from ulcers?

A

Mucosal defense

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is DU?

A

Occurs in the duodenum in which patients produces more acid mainly at night (basal secretion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is GU?

A

Occurs in the stomach in which patient produce more or diminished acid with a weakened mucosal defence and reduced bicarb production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

PUD are an imbalance between what 2 factors?

A
  1. Mucosal defensive
  2. Damaging

Damaging factors such as acidity, pepsin secretion, infection, NSAIDs outweigh defensive mechanism (bicarb, mucus, epithelial regeneration, PG, mucosal BF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What factors cause PUD? How do you fix the imbalances?

A

1. Hypersecretion of acid (pepsin): Acid Reducing Agents → [Antacids, H2-Blockers, Proton-pump inhibitors (PPIs)]
2. GI infection by H. pylori: Antibiotics → [Amoxicillin, Clarithromycin, Metronidazole]
3. Chronic use of ulcerogenic drugs: Gastric mucus/Cytoprotective agents → Prostaglandin analogue [Misoprostol], Sucralfate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe how gastric acid gets secreted?

A
  1. Input from Postganglionic cholinergic fibers and gastrin on the CCK2 on the parietal cells -> Gq-PLC-IP3 -> Ca2+ dependent pathway -> K,H ATPase
  2. Input from postganglionic cholinergic fibers to ENS -> ECL cel that releases histamine to H2 receptors -> Gs-cAMP-PKA pathway -> K,H ATPase
  3. Neural input from vagus nerve on M1 the superficial epithelial cell (gut) -> mucus and bicarb secretion
Enterochromaffin-like (ECL) cell, Enteric nervous system (ENS), Cholecystokinin receptor 2 (CCK2)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Identify where factors and pharm target in gastric secretion?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What histamine receptors are found in the gut?

A

H2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the components of mucus?

A

Consists of water (95%), phospholipids, and glycoproteins (mucin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What cell contains a mucus-bicarb phosphilipid layer?

A

Mucus and bicarbonate are secreted by gastroduodenal surface epithelial cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the precursors of prostaglandins?

A

From phospholipid-arachidonic acid that is formed by phopholipase A2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What PGs strains are the gastrium?

A

PGI1 and PGE2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the function of gastric PG?

A
  1. Regulate the release of mucosal bicarb and mucus, inhibit parietal cell secretion, maintain mucosal bloof flow
  2. Directly inhibit gastric acid secretion by parietal cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the most potent suppresor of Acid-reducing agent? Where does it target?

A

PPIs block the final step in acid production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What the clinically used PPIs?

A
  1. Prilosec (Omeprazole) and S-isomer, Nexium (Esomeprazole)
  2. Prevacid (Lansoprazole) & its R-enantiomer, Dexilant (Dexlansoprazole)
  3. Aciphex (Rabeprazole)
  4. Protonix (Pantoprazole)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the MOA for PPIs?

A
  1. Prodrug diffuses into parietal cells and accumulates in acidic secretory canaliculi
  2. Activated by acid-catalyzed formation of a tetracyclic sulfenamide -> drug becomes trapped by ionization
  3. Activated form then binds covalently with sulfhydryl groups of the H+/K+-ATPase, irreversibly inactivating the pump
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How should you administer PPIs?

A
  1. Several doses are required for max suppression because pumps are not active simultaneously
  2. Pumps increase after fasting so PPIs should be given before meals
  3. Drugs that inhibit acid secretion decrease PPI effectiveness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What PPIs are given are enteric coated gelatin capsules?

A
  1. Prilosec (Omeprazole)
  2. Dexilant (Dexlansoprazole)
  3. Nexium (Esomeprazole)
  4. Prevacid (Lansoprazole)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What PPIs are given as enteric-coated granules powder for suspension?

A

Prevacid (Lansoprazole)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What PPIs are given as an enteric coated tablet?

A
  1. Prilosec (Omeprazole)
  2. Protonix (Pantoprazole)
  3. Aciphex (Rabeprazole)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What PPI is given with bicarb? Dosage form?

A

Omeprazole as a capsule for oral suspension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

ADME of PPIs?

A

Rapidly absorbed
Highly protein bound
Extensively metabolized by CYPs (CYP2C19 and 3A4)
Low F (<90%)

32
Q

What is the dosage adjustment of PPIs?

A

Chronic renal failure -> does not cause drug accumulation with once-a-day dosing
Hepatic disease -> reduces clearances of Nexium (esomeprazole) & Prevacid (lansoprazole)
Severe hepatic disease require dose reduction

33
Q

What are the indications of PPIs?

A

GERD: Non-erosive and erusive reflux diseases, esophageal complications of reflux disease
PUDs (both DU and GU): H.pylori-associated ulcers and NSAID-associated ulcers

34
Q

How does PPIs target H.pylori?

A
  1. Direct antimicrobial properteies are minor
  2. Increase intragastric pH
  3. Lower MIC of antibiotics against H pylori
35
Q

What is the “triple therapy” for H.pylori?

A
  1. Any PPIs
  2. Clarithromycin
  3. Amoxicillin or metronidazole
36
Q

What PPIs are indicated for NSAID-associated ulcers?

A
  1. Prevacid (Lansoprazole)
  2. Nexium (Esomeprazole)
37
Q

What are the types of ADRs of PPIs?

A

Generally, extremely safe
Reduction in PO B12 absorption because it requires an acid environment
Respiratory and enteric infections due to lack of acid that prevent colonization and infection
Hypergastremia → hyperplasia of ECL and parietal cells → transient rebound acid hypersecretion

38
Q

What are the DDIs of that prevent PPI effectiveness?

A

Decreased gastric acid may alter absorption of those drugs which require acidic environment for absorption

Ketoconazole, itraconazole, digoxin, atazanavir, ampicillin

39
Q

How are PPIs metabolized? How does it afftect it ADME?

A

CYP2C19 & CYP3A4
1. Short half-lives -> lower ADR
2. Clopidogrel requires CYP2C19 for activation

40
Q

What are the approved H2RAs? Dosage forms?

A
  1. Tagamet (Cimetidine)
  2. Zantac (Ranitidine)
  3. Pepcid (Famotidine)
  4. Axid (Nizatidine)

PO, Nizatinidine is also available as IV or IM

41
Q

Rank the potency of H2RAs?

A

Famotidine&raquo_space;» Ranitidine = Nizatidine&raquo_space; Cimetidine

42
Q

What is more potent, H2RA or PPIs?

43
Q

What is the MOA of H2RAs?

A
  1. Reduce acid secretion stimulated by histamine release from ECL cell and by gastrin and Ach
  2. Inhibit basal acid secretion (useful for DU)
44
Q

Describe the ADME of H2RAs?

A

Absorbed rapidly in the intestine and undergoes first pass metabolism (50% F) -> Cimetidine, Zantac (ranitidine), Pepcid (famotidine)
Duration of action depends on the dose given
Poorly bound to plasma proteins
Eliminated renally (glomerular filtration & renal tubular secretion) with a small fraction of hepatic metabolism clearance

45
Q

How should H2RAs be dosed?

A

Moderate-severe renal insufficiency: Dose reduction required
Hepatic insufficiancy: No adjustment required

46
Q

What is H2RA has little first-pass metabolism?

A

Nizatidine

47
Q

What are the minor ADRs of H2RAs?

A
  1. Diarrhea
  2. HA
  3. Drowsiness
  4. Fatigue
  5. Muscular pain
  6. Constipation
48
Q

What are the ADRs associated with long-term cimetidine use? Why?

A

Men: Gynecomastia or impotence
Women: Galactorrhea
1. Inhibits binding of dihydrotestosterone to androgen receptors
2. Inhibtis metabolism of estradiol and increases prolactin

49
Q

What H2RAs fetal toxic?

A

Can cross the placenta and secreted in breast milk.

Showed no harm in fetus, but may in nursing infants

50
Q

What are the downsides of using H2RAs chronically?

A

Tolerance may develop leading to secondary hypergastrinemia that stimulates more histamine release from ECL cells

51
Q

What are the indications for H2RA?

A

GERD and PUD

52
Q

What are the DDIs of H2RAs?

A

Cimetidine inhibits CYP1A2, CYP2C9, CYP2D6, CYP3A4 interfering with a large number of drugs

53
Q

What produces most of the PG?

A

Gastric mucosa

54
Q

Why are PGE2 considered gastroprotective?

A

Cytoprotective
1. Increase mucin and bicarb secretion
2. Increase mucosal blood flow
3. Suppress acid

55
Q

What are the PG analogs?

A

Cytotec (Misoprostol) - synthetic analog of PGE1

56
Q

What is the MOA of Cytotec?

A

Misoprostol binds to EP3 receptor on parietal cells → stimulates Gi pathway → decreasing icAMP → decreasing gastric secretion

Inhibition of gastric acid secretion is dose-dependent

57
Q

Describe the ADME of Misoprostol?

A

Rapidly absorbed after oral administration
Metabolized to free acid
Short half-life therefore T-QID
Excreted in urine → NO reduction in renal insufficiency

58
Q

What are the DDIs of Cytotec?

A

Food and antacids → ↓ absorption rate → delayed effect and ↓ plasma concentration of the active metabolite

59
Q

What are the ADRs of Misoprostol?

A
  1. Diarrhea (dose-related) w/ or w/o abdominal pain and cramps
  2. Exacerbations of IBD → CI
  3. ↑ uterine contractility → CI in pregnancy
60
Q

Indications of Cytotec?

A
  1. NSAID-induced mucosal injury
  2. Rarely used
61
Q

What is Sucralfate?

A

Carafate is a sucrose salt complexed as a sulfated aluminum hydroxide

62
Q

What is the MOA of Carafate?

A
  1. Acidic environment separates sucrose salt from aluminum → undergoes crosslinking to produce a viscous, sticky polymer that adheres to epithelial and ulcers for 6hr
  2. Negatively charged sucrose sulfate binds to positively charged proteins in the base of ulcers or erosion → forming a physical barrier
  3. Stimulates mucosal prostaglandin and bicarbonate secretion.
63
Q

What contributes to mucosal erosion and ulcerations?

A

Pepsin mediated hydrolysis of mucosal proteins

64
Q

What are the indications of carafate?

A

Prevention of stress-related bleeding to prevent the nosocomial pneumonia in critically ill patients by acid inhibitory therapies

65
Q

What are the ADRs of Carafate? CI

A

No systemic ADR due to limited absorption

Constipation from slight aluminum salt absorption

Not used long term in patients with renal insufficiency → due to aluminum.

66
Q

What are the DDIs of sucralfate?

A

May bind to other meds impairing its absorption

Phenytoin, digoxin, cimetidine, ketoconazole, fluoroquinolone antibiotics

67
Q

What are the indications of antacids?

A

Mainstay for treatment of acid-peptic disorders until H2RAs and PPIs

Heartburn, dyspepsia

68
Q

What is the MOA of antacids?

A
  1. Weak base that ↓ intragastric acidity, neutralizing HCl forming a salt and water
  2. Acid-neutralization capacity (ANC) of antacids → highly variable
69
Q

What are examples of antacids?

A
  1. Sodium bicarb (Alka Seltzer)
  2. Calcium carbonate (Tums)
  3. Antacids containing Mg(OH)2 or Al(OH)3
70
Q

How does Sodium bicarb work as an antacids? What products does is produce?

A

Reacts with HCl → produce CO2 and NaCl:

CO2 → gastric distention and belching
Unreacted alkali → absorbed → metabolic alkalosis in patients with high doses or renal insufficiency
NaCl → Exacerbate fluid retention in patients with HF and renal insufficiency

71
Q

How does calcium carbonate differ from Alka Seltzer?

A
  1. Less soluble and reacts more slowly with HCl
  2. Forms CO2 and CaCl2
72
Q

How does Magnesium and aluminum differ from calcium and sodium antacids?

A
  1. No gas, belching, metabolic alkalosis
  2. Unabsorbed Mg2+ salts → Osmotic diarrhea & Al3+ salts → Constipation
  3. Absorbed and excreted by the kidneys (not for renal insufficiency)
73
Q

What are the DDIs of antacids?

A
  1. Bind to other drugs and reduce its absorption
  2. ↑ intragastric pH → altering dissolution or solubility of drugs
74
Q

What are the Prokinetic / Motility Enhancing Drugs?

A

Bethanechol (Cholinomimetic agents)

Reglan (Metoclopramide)

75
Q

What is the MOA of Bethanechol (Cholinomimetic agents)? Indication?

A

Stimulate muscarinic M3 receptors on muscle cells and at myenteric plexus synapses

GERD and Gastroparesis, but rarely used

76
Q

What is the MOA of Reglan (Metoclopramide)? Indication?

A

D2-receptor + 5-HT3 receptor antagonist
1. ↑ esophageal peristaltic amplitude, ↑ lower esophageal sphincter pressure, ↑ gastric emptying → Treat GERD
2. Blocks dopamine D2 receptors in chemoreceptor trigger zone (CTZ) of the medulla (area postrema → Antinausea and Antiemetic action

77
Q

GIT activity with dopamine receptors?

A

Inhibits cholinergic smooth muscle stimulation

Drug Action II (28 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions